Stay updated on Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial

Sign up to get notified when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:58:11.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A sitewide notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the existing 403 error page.
    Difference
    1%
    Check dated 2026-10-24T15:24:32.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:12:58.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:17:54.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The 403 error content was removed, restoring access to the study details view for the trial. Users can now view the page content.
    Difference
    0.5%
    Check dated 2026-09-26T18:13:43.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content. This indicates access to the NCT03014622 trial details is blocked.
    Difference
    17%
    Check dated 2026-09-19T20:23:02.000Z thumbnail image

Stay in the know with updates to Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of DaxibotulinumtoxinA in Glabellar Lines Clinical Trial page.